Balaji Prasad

Stock Analyst at Barclays

(3.37)
# 1,010
Out of 5,043 analysts
132
Total ratings
47.58%
Success rate
3.58%
Average return

Stocks Rated by Balaji Prasad

Evolus
Mar 5, 2025
Maintains: Overweight
Price Target: $22$25
Current: $7.22
Upside: +246.26%
Amneal Pharmaceuticals
Mar 3, 2025
Maintains: Overweight
Price Target: $10$11
Current: $10.25
Upside: +7.32%
Pacira BioSciences
Feb 28, 2025
Maintains: Overweight
Price Target: $17$24
Current: $21.33
Upside: +12.52%
Viatris
Feb 28, 2025
Maintains: Underweight
Price Target: $12$9
Current: $10.42
Upside: -13.63%
Jazz Pharmaceuticals
Feb 27, 2025
Maintains: Overweight
Price Target: $190$200
Current: $139.33
Upside: +43.54%
Elanco Animal Health
Feb 26, 2025
Maintains: Overweight
Price Target: $20$19
Current: $22.27
Upside: -14.68%
Tarsus Pharmaceuticals
Feb 26, 2025
Maintains: Overweight
Price Target: $62$60
Current: $68.17
Upside: -11.98%
Zoetis
Feb 14, 2025
Maintains: Overweight
Price Target: $242$244
Current: $147.53
Upside: +65.39%
Organon & Co.
Feb 14, 2025
Maintains: Overweight
Price Target: $26$24
Current: $7.06
Upside: +239.94%
Phibro Animal Health
Feb 10, 2025
Maintains: Underweight
Price Target: $20$22
Current: $41.70
Upside: -47.24%
Maintains: Overweight
Price Target: $481$520
Current: $647.40
Upside: -19.68%
Maintains: Overweight
Price Target: $28$26
Current: $19.61
Upside: +32.59%
Maintains: Overweight
Price Target: $17$17
Current: $14.47
Upside: +17.48%
Maintains: Overweight
Price Target: $22$18
Current: $8.13
Upside: +121.40%
Maintains: Equal-Weight
Price Target: $2.5$10
Current: $3.61
Upside: +177.01%
Maintains: Overweight
Price Target: $8$7
Current: $1.60
Upside: +337.50%